"Central Garage 2120 Vivien Thomas Way Nashville, TN 37212 Access this garage at the intersection of 21st Ave. and Vivien Thomas Way. After turning onto Vivien Thomas Way, the Central Garage garage entrance is on the left."

During the past decade, Vanderbilt Medical Center - IPF Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vanderbilt Medical Center - IPF Center" are "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Vanderbilt Medical Center - IPF Center" in a lesser frequency.

Most popular intervention types in "Vanderbilt Medical Center - IPF Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bosentan" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt Medical Center - IPF Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vanderbilt Medical Center - IPF Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vanderbilt Medical Center - IPF Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt Medical Center - IPF Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".